IAC demonstrates safety for treating brain metastases in palliative patients, highlighting the need for further efficacy studies.
IAC can be applied as a safe method for palliative patients with BCBM. Further studies are necessary to definitively determine its efficacy.
No takes yet. Share an insight, caveat, or question.
Adwan et al. (2026) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: